Disability UK Online News Journal, Disability Business Directory, All In One Business Solutions

Day: September 20, 2022

Gaviscon Shortages.

What is Gavison? Gaviscon is a drug that was created in the 60s to early 70s in order to treat acid reflux/LPR disease. It’s made up of 5 key ingredients: calcium carbonate, alginates, aluminum hydroxide, magnesium carbonate, and sodium bicarbonate. Gaviscon is a non-prescription medicine, which is taken by mouth to treat heartburn and gastroesophageal reflux disease. Gaviscon is one of the most popular brands used to treat these issues and works by forming a protective layer that floats on top of the contents of your stomach, therefore stopping stomach acid from escaping into your food pipe. Like antacids in general, Gaviscon is available as a solid, syrup, or tablet. It is produced and distributed in the UK, Ireland, Australia, and Malaysia by Reckitt Benckiser, in the US by GlaxoSmithKline, and in Canada.

Gaviscon Shortages

Reckitt Benckiser the manufacturer of many household brands like Dettol, Cilitbang, and Gaviscon has been accused by the Office of Fair Trading of creating a monopoly in the market for its heartburn drug Gaviscon.

Reckitt could be fined tens of millions of pounds. In Reckitt’s defense, they released a statement stating they believed that it competed fairly in all of its operations. The OFT moved against the company after a whistleblower made the allegation to BBC’s Newsnight in 2008.

However, if you go beyond all the smoke, mirrors, and jargon this is at the expense of the consumer who has to suffer whilst the giants play a game of monopoly on their health.

The former senior Reckitt executive claimed that the makers of Gaviscon maintained an effective monopoly on the market for years after the stomach medicine came off patent. So if that was the case where are their global shortages?

As someone who suffers from heartburn and Dysphagia, I am sick to the back teeth of excuses. I would buy anything to ease the discomfort regardless if it was a famous brand or not. What Reckitt Benckiser are doing is stopping the manufacturing of their cheaper product in favor of the dearer one to make more profits at the expense of the people that rely on the drug. The pharmacies that say they do not know why they are having shortages are trying to basically fool the consumer. They know full well why this drug is in short supply, but choose not to say.

A senior official at Reckitt Benckiser suggested certain people within the organization plotted to create obstacles to stop rival manufacturers from selling cheap generic copies. The whistleblower alleged the firm had “cheated the NHS” and could have saved it “millions of pounds”.

Reckitt Benckiser (RB) said in response to the OFT announcement: “The OFT has stressed that no assumptions should be made at this stage. RB believes it competes fairly and within the letter and spirit of the law in all of our operations, and has co-operated fully with the OFT throughout its inquiry. So if that is the case why is the UK NHS suing them?

“Gaviscon Advance is a second generation product, superior to ‘Gaviscon Original’. I was on the ‘Original’ for many years then had the upgrade to ‘Gaviscon Advance’ which was launched to provide patients with effective and long-lasting relief from heartburn and indigestion, thus replacing the cheaper version which was taken off the market.

“RB will now review the OFT statement and respond accordingly.” According to ‘RB’ Gaviscon was hit by a global shortage due to one key ingredient, a product that many people around the world rely on but cannot get. So you are telling me you can not farm algae anywhere else than Norway? These seaweed species are used to create medical-grade sodium alginate, which is the key ingredient in Gaviscon. “The shortage is a consequence of poor weather conditions and low harvest yields,” the company said in a statement. “Only alginates derived from a specific species have the precise characteristics to be used in the manufacture of effective heartburn and indigestion products such as Gaviscon.”

There should be other rival pharmaceutical companies that can produce better and cheaper alternatives and once they find themselves on the market I will be buying from ‘RB’ competitors because no one should have a gun pointing to their head that says buy from us or else. If the covid vaccine was invented in record time a dupe alternative for Gaviscon could also be invented.

Knowing what I know now I will be looking to buy less from this company across the board for all my household items.

Reckitt informed both customers about the shortage of sodium alginate and informed them they were working with supply partners to put products back on shelves. “Due to global supply chain challenges, we are experiencing shortages with some Gaviscon products. We are continuing to monitor supply and are working with our suppliers to improve availability,” a Coles spokesperson said.

Gaviscon said that “as a responsible company” it recognized its duty to produce unconstrained access to its product but, unfortunately, the shortage of medical-grade sodium alginate was impacting this. “We are working diligently with our supply partners to secure as much production as possible and will do our best to ensure our consumers, patients, and healthcare professionals have access to the heartburn and indigestion treatment they love and trust,” Gaviscon said.

Lemsip, which is also manufactured by Reckitt Benckiser, contains paracetamol and phenylephrine and is used for the temporary relief of symptoms of colds and flu, including body aches and pains, sore throat, headache, and nasal congestion. “Unfortunately, we are also currently experiencing supply chain issues for Lemsip, which means customers might not be able to find this product on our shelves. We understand the frustration for customers and are working hard with our supplier to improve availability as quickly as possible.”

Is that because the special lemon only grown in a certain area in Spain is not producing enough lemons because there are not enough bees?

The truth behind big supermarket shortage. NHS sues Gaviscon maker Reckitt Benckiser.

The NHS in England has launched legal action against Reckitt Benckiser, the maker of heartburn medicine Gaviscon.

According to High Court documents, Health Secretary Andrew Lansley is leading the action on behalf of health authorities and primary care trusts. The Department of Health refused to comment on the subject of the suit. Reckitt Benckiser was fined £10m last year for abusing its dominant market position in the supply of heartburn remedies to the NHS. A spokesman for Reckitt said the company could not comment as it had not been served with any papers. Papers lodged at the High Court show Reckitt is being sued collectively by all 10 Strategic Health Authorities and 144 Primary Care Trusts in England, as well as Andrew Lansley as Secretary of State for Health.

‘Dominant position

The Office of Fair Trading (OFT) said in October last year that Reckitt had restricted competition in the supply of heartburn medicines.

The household products maker withdrew the original Gaviscon from the NHS in 2005 and patients were transferred to Gaviscon Advance Liquid. This happened after Gaviscon’s patent had expired, but before a generic name had been assigned to it, the OFT said. That meant that prescriptions were issued for Gaviscon Advance, rather than pharmacists being able to choose a cheaper generic alternative. The OFT’s inquiry followed an investigation by the BBC’s Newsnight program in 2008.

Gaviscon is one of the most heavily prescribed medicines within the NHS. Confidential papers leaked to the program by a whistleblower showed it was also very profitable, with a gross margin of 77% in 2003.

The chief executive of the OFT, John Fingleton, said at the time: “This case underlines our determination to prevent companies with a dominant position in a market from using their strength to seek to restrict competition from rivals”.In response to the OFT’s fine, Reckitt said that it had believed it was acting within the law at the time and respected the watchdog’s findings.

BBC News – NHS sues Gaviscon maker Reckitt Benckiser

NHS sue Gaviscon maker £90 m, ‘rip-off’ after costlier heartburn forced on doctors.

Andrew Lansley will claim compensation at the High Court for the millions allegedly overpaid The makers of Gaviscon are being sued for nearly £90million for overcharging the Health Service for the heartburn treatment. Reckitt Benckiser allegedly charged doctors for a more expensive version of the drug when a cheaper one was available.

The firm, which also produces the Nurofen, Clearasil, and Durex brands, has already been fined £10.2million by the Office of Fair Trading after admitting to breaking UK and EU competition law over its sale of Gaviscon to the NHS.

Now Health Secretary Andrew Lansley, ten strategic health authorities, and 146 primary care trusts are suing the pharmaceutical giant at the High Court for the millions they say were overpaid. The alleged abuse centres on Reckitt Benckiser’s Gaviscon Original treatment, one of the most commonly prescribed branded drugs on the NHS. The product’s patent was due to run out in 2005, allowing rival firms to produce copycat versions, known as ‘generics’, for a vastly lower price.

But Reckitt took steps that appeared to block this process.

It removed Gaviscon Original from the NHS-approved list of drugs, but it did not propose a generic name for the drug which would have helped a cheap replacement version to come onto the market.

Instead, it put forward a more expensive Reckitt Benckiser product, Gaviscon Advance, which was still within the patent. Doctors wishing to prescribe a treatment for heartburn had no other option available. Yet Gaviscon Original remained on sale and could be picked up over the counter in pharmacies.

The person who leaked the documents said at the time: ‘Reckitt cheated the Health Service. ‘It could have saved the NHS millions of pounds. I felt it had to be exposed.’

Gaviscon is one of the most prescribed drug brands in Britain The NHS spends a fifth of its annual £110billion budget – around £22billion – on drugs. The Commons public accounts committee has estimated the NHS could save £200million a year without affecting patient care by GPs prescribing lower-cost but equally effective treatments.

Surely there has to be an alternative rather than letting patients suffer?

Reckitt Benckiser said it was ‘shocked’ by the allegations, adding: ‘Reckitt Benckiser is a responsible company.’ If it was responsible why are people suffering at the expense of this pharmaceutical company?

Although it denied cheating the NHS, it admitted anti-competitive behavior and said it was ‘unhappy with some of the language and the sentiment … in the [leaked] internal correspondence, which is inappropriate.

The amount of money sought from Reckitt Benckiser – £90million – coincidentally matches the pay and rewards package of its boss Bart Becht, one of the best-rewarded chairmen of an FTSE100 company. Becht, a Dutchman, has led Reckitt Benckiser since the company was formed in 1999 through the merger of Britain’s Reckitt & Colman and Holland’s Benckiser. He once said that his company makes ‘very stupid products.

Becht is famous not only for his huge salary but also for his generosity to charity. In 2009 he gave stock options worth £110million to good causes.

If he is reading this he can donate here considering I rely on the drug and am in discomfort.

https://www.managementtoday.co.uk/gaviscon-scam-claims-hard-digest-reckitt-benckiser/article/985844

#gaviscon #gavisconadvanced #gavisconshortages #nhssues #ReckittBenckiser #ReckittBenckiserbeingsued #nhssuesReckittBenckiser

GP (Doctor) Negligence Evidence.

GP (Doctor) Negligence Evidence.

** This post is primarily for the UK. I have written several articles about my GP (Doctor) Negligence and Doctor-Patient Confidentiality in recent times. I am for my own records posting evidence they have only confirmed my letters have been put on the system but both times have not been actioned. Furthermore, I have been in communication with several people, not only relating to this particular surgery but others around the UK also encountering similar problems. I have now discovered why GP (Doctor) Surgeries are backlogged… read more…

Local doctors’ surgeries across the UK are either closing or their clinicians are retiring early.

The impact of the aftermath of the pandemic has caused a strain on doctors and other workers in local GP practices which have seen some “struggling to maintain regular services” which has meant some closing surgery doors to all but the most urgent cases.

Playing “Russian Roulette”, with people’s lives is what is happening as each day brings new absences. Those with overall responsibility for general practice, such as NHS England and the Clinical Commissioning Groups (CCGs), have had “no backup plan”.

Doctors revolt over pension tax rules: What sparked the row? | This is Money

A survey carried out by the Royal College of GPs (RCGP) found that at least a third of doctors were planning to retire in the next five years, leaving 14,000 fewer GPs than are currently working.

Addressing the Health and Social Care Committee, retired GP Dr. Andrew Green said, “We need to accept that 10-minute appointments are not safe. The only way that you can run a 10-minute appointment surgery on time is by cutting corners.

Therefore introduce a questionnaire to be filled out by patients who could then write about their ailments for the doctors to review” similar to what I have done, although my surgery is as helpful as a chocolate fire guard. A ten-minute appointment can then be reduced to two or can be done online using encryption software”

According to “herd immunity” policy, which has allowed the coronavirus to rip through the population in successive and ever-higher waves of infection, has placed intolerable burdens on NHS hospitals.

“This is all smoke and mirrors and I believe the herd immunity is working because most people would have received their vaccinations. I believe it is down to the doctors themselves not managing their time properly or insufficient staff quotas”.

This has produced a monumental backlog of those waiting for vital elective procedures, which now exceeds 6 million. In turn, this increases pressure on GPs, who must manage patients on excessively long waiting lists, with some people forced to live with excruciating pain or physically limiting conditions. UK doctor’s surgeries forced to close doors to all but urgent care needs – World Socialist Web Site (wsws.org)

However, more common reasons cited for wishing to depart included feeling exhausted, overworked, and underpaid, as well as having too little time to do their jobs to the desired standard.

Senior doctors in the NHS are reducing their hours, turning down extra work, and even retiring early to avoid being hit with huge tax bills on their pensions, a report reveals. NHS consultants ‘turning down work to avoid huge pension tax’ | NHS | The Guardian

The government’s enforced collapse of free universal healthcare services will be used by it to push for the further privatization of the sector.

“Just mark my words and won’t be long before our NHS collapses and we will have to have to have insurance or pay towards our healthcare”.

UK doctor’s surgeries forced to close doors to all but urgent care needs – World Socialist Web Site (wsws.org)

EVIDENCE

Evidence of the emails I received to state my letters were logged on the system.

FINAL NOTES:

To recap I wrote a letter which I emailed last year 9 pages long and this year 15 pages long, it was put on the system and both times never actioned.

I have been told previously by my surgery if I do not like how things are run to change doctors (I am not the only one judging by the Google Reviews). It is easier said than done if you have social disconnection problems, run a business, and do not have time to register at a new surgery never mind the shortfall on the prescribed medication, whilst you wait for your registration to be approved and your medical records sent over.

The NHS are playing “Russian roulette”, put it this way my doctor’s surgery, in particular, most definitely is playing with people’s health.

If you are unhappy you should first address your practice manager or write to your head doctor failing that you can complain to the NHS (see links below).

I know I could take this further and I will one day, but at the moment I am dependent on my medication, albeit there is a shortage of Gaviscon.

NHS NEGLIGENCE COMPLAINTS

https://www.mind.org.uk/about-us/our-policy-work/you-and-your-gp/for-gp-patients/

https://www.nhs.uk/using-the-nhs/about-the-nhs/how-to-complain-to-the-nhs/

https://www.nhs.uk/service-search/other-services/Patient-advice-and-liaison-services-(PALS)/LocationSearch/363

https://www.nhs.uk/service-search/other-services/Clinical-Commissioning-Group/LocationSearch/1

https://www.cqc.org.uk/contact-us/how-complain/complain-about-use-mental-health-act

https://www.ombudsman.org.uk/

https://www.ombudsman.org.uk/publications/my-expectations-raising-concerns-and-complaints

HOW TO COMPLAIN

https://www.nhs.uk/using-the-nhs/about-the-nhs/how-to-complain-to-the-nhs/

https://www.nhs.uk/service-search/other-services/Patient-advice-and-liaison-services-(PALS)/LocationSearch/363

(Recommended)

https://www.ombudsman.org.uk/

#nhs #doctorssurgeries #generalpractitioners #dutyofcare #doctorspractice #negligence